Hsbc Chinese Equity

For Fidelity Retirement Master Trust, please note: 有關富達退 …

away from Chinese health care names amid uncertainties surrounding the possible sanctions by Washington. The position is held as it is best positioned to benefit from the booming China biologics industry while we see probability of sanction risks remain low. The underweight position in HSBC Holdings held back relative performance.

  Chinese, Hsbc